eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	SHUTTLE PHARMACEUTICALS, INC
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A specialty pharmaceutical company founded in 2012, with the goal of becoming the first U.S. pharmaceutical company focused on the development and commercialization of innovative first-in-class drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy (“RT”).
Lead Underwriter	N/A
Co-Managers	Self-underwritten
Initial Shares	45,00,000
Revised Initial Shares	N/A
Initial Price	$8.00-$8.00
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A